The drug works by essentially forcing our cells to "spit out" dangerous protein clumps involved in Alzheimer's.

Semaglutide, the weight management drug sold as Ozempic and Wegovy, may reduce the risk of Alzheimer's disease by 40% to 70% ...

Alzheimer’s disease is a ... that semaglutide may protect against neurodegeneration and neuroinflammation,” said Xu, who also ...

There is a lot of outrage that the new Alzheimer’s drug donanemab is being refused on the NHS. But there are good reasons for ...

Could the drug that's changing the weight loss industry also protect older adults against the most common form of dementia?

Ozempic and Wegovy, made by Novo Nordisk, are now listed as available across all doses on the FDA’s drug shortage list. But ...

Glioblastoma is the most common and deadliest form of brain cancer. Patients face a bleak prognosis – the average survival ...

may help lower Alzheimer’s disease risk in people with type 2 diabetes, when compared to seven other drugs used to treat diabetes. Additionally, diabetes can potentially damage blood vessels in ...

People with Type 2 diabetes taking semaglutide appeared to have a significantly lower risk of developing Alzheimer's compared ...

A common diabetes and weight-loss drug may also reduce the risk of Alzheimer’s disease, according to a new study. American ...

Researchers have discovered that semaglutide weight loss drugs like Ozempic may reduce the risk of early-onset colorectal cancer (CRC) in diabetes patients.

Scientists at Case Western Reserve University’s School of Medicine have discovered that semaglutide, a well-known drug used ...